SCHEMBL23950570

SCHEMBL23950570

O=c1[nH]cnc2c(-c3cccnc3)nc(-c3ccc(Cl)cc3)cc12

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PSD A5PKW4 3/20 0.44
PIM1 P11309 3/20 0.43
CYP19A1 P11511 3/20 0.42
PARP1 P09874 2/20 0.41
PDGFRB P09619 2/20 0.41
AURKA O14965 1/20 0.41
DAPK3 O43293 1/20 0.41
JAK2 O60674 1/20 0.41
PRKD3 O94806 1/20 0.41
MAP4K4 O95819 1/20 0.41
PAK4 O96013 1/20 0.41
ABL1 P00519 1/20 0.41
CSF1R P07333 1/20 0.41
RET P07949 1/20 0.41
IGF1R P08069 1/20 0.41
MET P08581 1/20 0.41
FGFR1 P11362 1/20 0.41
PDGFRA P16234 1/20 0.41
PRKACA P17612 1/20 0.41
FLT1 P17948 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25463634 0.89 PIM1 (0.44) PIM1CYP19A1PARP1PDGFRBRPS6KA3
SCHEMBL26275700 0.87 PIM1 (0.43) PIM1CYP19A1PARP1PDGFRBKDM4E
SCHEMBL30101918 0.86 PIM1 (0.45) PSDPIM1PARP1NPY5R
SCHEMBL23950529 0.86 PIM1 (0.45) PSDPIM1PARP1NPY5R
SCHEMBL23390340 0.83 PIM1 (0.40) PSDPIM1PARP1QPCTQPCTL
SCHEMBL29611095 0.83 PIM1 (0.40) PSDPIM1PARP1QPCTQPCTL
SCHEMBL31472809 0.82 PIK3CA (0.48) PIM1PDGFRBAURKAMAPK8DYRK1A
SCHEMBL23416832 0.79 PIM1 (0.38) PSDPIM1PARP1PDGFRBCLK2
SCHEMBL23950718 0.78 PSD (0.43) PSDPIM1CYP19A1NPY5RKDM4E
SCHEMBL26295805 0.78 PIM1 (0.46) PIM1PARP1CLK2DYRK1ANPY5R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230295152-A1 PYRIDOPYRIMIDINONE DERIVATIVES AS AHR ANTAGONISTS SENDA BIOSCIENCES, INC. (US) 2023-09-21 US disclosed
WO-2021210970-A1 PYRIDOPYRIMIDINONE DERIVATIVES AND THEIR USE AS ARYL HYDROCARBON RECEPTOR MODULATORS DONG-A ST CO., LTD. (KR) 2021-10-21 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230295152-A1 PYRIDOPYRIMIDINONE DERIVATIVES AS AHR ANTAGONISTS AHR, ARNT, AIPL1 PSD 3620/4885PIM1 2854/4885CYP19A1 158/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.